A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia. [electronic resource]
Producer: 20191218Description: 6185-6194 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Antigens, CD19 -- immunology
- Batch Cell Culture Techniques
- Cell Separation
- Female
- Humans
- Immunity, Cellular
- Immunotherapy, Adoptive -- adverse effects
- Leukemia -- diagnosis
- Lymphocyte Count
- Lymphoma -- diagnosis
- Male
- Middle Aged
- Receptors, Antigen, T-Cell -- genetics
- Recombinant Fusion Proteins -- genetics
- Survival Analysis
- T-Lymphocytes -- immunology
- Transgenes
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.